Rudge S R, Perrett D, Swannell A J, Drury P L
J Rheumatol. 1984 Apr;11(2):150-2.
During studies of the metabolism of disodium aurothiomalate in patients with rheumatoid arthritis we have found that its pharmaceutical preparation. Myocrisin, contains 4 to 8% of free thiomalate. To establish whether the free thiomalate previously reported in plasma and urine of patients receiving Myocrisin is a true metabolite or results from this impurity, we prepared aurothiomalate containing 0.1% thiomalate. Intramuscular injection of the purified drug to 2 healthy subjects produced easily detectable levels of thiomalate in both plasma and urine; 7.7 and 9.8% respectively of the doses given were recovered in urine as free thomalate within 4 h. Thus, dissociation of disodium aurothiomalate does occur in vivo, releasing both gold and free thiomalate as potentially active forms.
在对类风湿性关节炎患者进行金硫代苹果酸钠二钠代谢的研究过程中,我们发现其药物制剂Myocrisin含有4%至8%的游离硫代苹果酸盐。为确定先前报道的接受Myocrisin治疗患者血浆和尿液中的游离硫代苹果酸盐是真正的代谢产物还是源于这种杂质,我们制备了含0.1%硫代苹果酸盐的金硫代苹果酸钠。对2名健康受试者肌内注射纯化药物后,血浆和尿液中均产生了易于检测到的硫代苹果酸盐水平;给药剂量的7.7%和9.8%分别在4小时内以游离硫代苹果酸盐形式在尿液中回收。因此,金硫代苹果酸钠二钠在体内确实会发生解离,释放出金和游离硫代苹果酸盐这两种潜在的活性形式。